Le Lézard
Classified in: Science and technology, Business
Subject: LIC

/C O R R E C T I O N -- Synopsys, Inc./


In the news release, IBM and Synopsys Accelerate 3nm Process Development with DTCO Innovations, issued 15-Aug-2018 by Synopsys, Inc. over PR Newswire, we are advised by the company that the headline, first paragraph and fifth paragraph should read "Post-FinFET" and/or "post-FinFET technologies" rather than "3nm" and/or "3-nanometer (nm)" as originally issued inadvertently. The complete, corrected release follows:

IBM and Synopsys Accelerate Post-FinFET Process Development with DTCO Innovations

Synopsys Manufacturing, IP, and Design Implementation Technologies Enable Industry's Only Complete DTCO Flow

MOUNTAIN VIEW, Calif., Aug. 15, 2018 /PRNewswire/ --

Highlights:

Synopsys, Inc. (Nasdaq: SNPS) today announced a collaboration with IBM to apply design technology co-optimization (DTCO) to the pathfinding of new semiconductor process technologies for post-FinFET technologies. DTCO is a methodology for efficiently evaluating and down-selecting new transistor architectures, materials and other process technology innovations using design metrics, starting with an early pathfinding phase before wafers become available. The collaboration will extend the current Synopsys DTCO tool flow to new transistor architectures and other technology options while enabling IBM to develop early process design kits (PDKs) for its partners to assess the power, performance, area, and cost (PPAC) benefits at IBM's advanced nodes.

"Process technology development beyond 7 nanometers requires the exploration of new materials and transistor architectures to achieve optimum manufacturability, power, performance, area, and cost. A major challenge for foundries is to converge on the best architecture in a timely manner while vetting all the possible options," said Dr. Mukesh Khare, vice president of Semiconductor Research, IBM Research Lab. "Our DTCO collaboration with Synopsys allows us to efficiently select the best transistor architecture and process options based on metrics derived from typical building blocks, such as CPU cores, thus contributing to faster process development at reduced cost."

In this collaboration, IBM and Synopsys are developing and validating new patterning techniques with Proteustm mask synthesis, modeling new materials with QuantumATK, optimizing new transistor architectures with Sentaurustm TCAD and Process Explorer, and extracting compact models with Mystic. Design rules and process assumptions derived from these process innovations are used to design and characterize a standard cell library while Fusion Technologytm at the block level using the Synopsys physical implementation flow based on IC Compilertm II place-and-route, StarRCtm extraction, SiliconSmart® characterization, PrimeTime® signoff, and IC Validator physical verification benefits the evaluation of PPAC.

The scope of the joint development agreement covers multiple facets, including:

"Synopsys has developed the only complete DTCO solution, from materials exploration to block-level physical implementation," said Dr. Antun Domic, chief technology officer at Synopsys. "IBM's extensive process development and design know-how makes them an ideal partner for extending our DTCO solution to post-FinFET technologies."

For more information on DTCO, visit www.synopsys.com/DTCO.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Softwaretm partner for innovative companies developing the electronic products and software applications we rely on every day. As the world's 15th largest software company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and is also growing its leadership in software security and quality solutions. Whether you're a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing applications that require the highest security and quality, Synopsys has the solutions needed to deliver innovative, high-quality, secure products. Learn more at www.synopsys.com.

Editorial Contact:
James Watts
Synopsys, Inc.
650-584-1625
[email protected]

 

SOURCE Synopsys, Inc.


These press releases may also interest you

at 11:05
Knight Therapeutics Inc. ("Knight" or "the Company") is pleased to announce it will be recognized on The Globe and Mail's 2024 Report on Business magazine's fifth annual Women Lead Here list. This annual editorial benchmark identifies top-level...

at 11:01
Trading resumes in: Company: Horizonte Minerals Plc. TSX Symbol: HZM All Issues: Yes Resumption (ET): 11:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...

at 11:00
Eagle Hill Consulting has earned another top workplace award, this time selected by The Washington Business Journal as a 2024 Best Places to Work in the extra-large sized company category. Eagle Hill also has earned multiple best workplace awards...

at 11:00
The Canadian Securities Administrators (CSA) today released two new reports: the Oversight Review Report of the Canadian Investment Regulatory Organization (CIRO) (Oversight Report) and the 2023 Annual Activities Report on the Oversight of CIRO and...

at 11:00
Noodoe, a global leader in electric vehicle (EV) charging solutions, is proud to announce its recent achievement in obtaining a General Services Administration (GSA) Multiple Award Schedule (MAS) contract. This significant milestone, marked by the...

at 11:00
Today, Syndio, the world's leading workplace equity analytics platform, announced Doug Aspland has joined the company as Chief Revenue Officer. Aspland brings more than two decades of experience developing sales strategy, scaling teams, and...



News published on and distributed by: